Protective effect of CCR5 δ32 heterozygosity is restricted by SDF-1 genotype in children with HIV-1 infection

AIDS

Volumn 15, Issue 11, 2001, Pages 1343-1352

  Sei, Shizuko ^a   Boler, Anne Marie ^b   Nguyen, Giao T ^b,c   Stewart, Sean K ^b,d   Yang, Quan en ^a   Edgerly, Maureen ^b   Wood, Lauren V ^b   Brouwers, Pim ^b,e   Venzon, David J ^b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c LLC   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

AIDS; CCR5 32 heterozygosity; Children; Disease progression; Genetic restrictions; HIV 1; SDF1 3 A polymorphism

Indexed keywords

CHEMOKINE RECEPTOR CCR5; PROTEINASE INHIBITOR; STROMAL CELL DERIVED FACTOR 1; VIRUS DNA;

3' UNTRANSLATED REGION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ARTICLE; BRAIN DISEASE; CAUCASIAN; CHILD; CONTROLLED STUDY; DISEASE COURSE; ETHNIC GROUP; GENE DELETION; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; NEGRO; PERINATAL INFECTION; PRIORITY JOURNAL; SURVIVAL RATE; T LYMPHOCYTE;

ADOLESCENT; ALLELES; BASE SEQUENCE; CHEMOKINES, CXC; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DNA, VIRAL; GENOTYPE; HETEROZYGOTE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CCR5; SEQUENCE DELETION; SURVIVAL ANALYSIS;

EID: 0035958794     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200107270-00003     Document Type: Article

References (66)

1. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
2. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
3. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
4. Identification of a major coreceptor for primary isolates of HIV-1
5. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
6. CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1
7. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
8. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
9. Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals
10. Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression
11. Naive and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: Implica-tip6s for transmission and pathogenesis
12. In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline
13. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
14. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
15. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply exposed individuals to HIV-1 infection
16. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
17. HIV-1 infection in a man homozygous for CCR5 delta 32
18. HIV-1 infection in an individual homozygous for CCR5 delta 32
19. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
20. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression
21. Association between CCR5 genotype and the clinical course of HIV-1 infection
22. Infectious cellular load in human immunodeficiency virus type 1 (HIV-1)- infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmission in homosexual couples
23. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro
24. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression
25. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation
26. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant
27. Genetic polymorphism of CCR5 gene and HIV disease: The heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression
28. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression
29. No evidence for an effect of the CCR5 delta32/+ and CCR2b 641/+ mutations on human immunodeficiency virus (HIV)-1 disease progression among HIV-1-infected injecting drug users
30. Chemokine receptor polymorphisms and human immunodeficiency virus disease progression
31. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression
32. The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection
33. Shorter survival of SDF1-3′A/3′A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infection
34. CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children
35. Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age
36. Role of CCR5 chemokine receptor gene in vertical human immunodeficiency virus type 1 transmission and disease progression
37. Distribution of CCR5delta32 in human immunodeficiency virus-infected children and its relationship to disease course
38. Prognostic value of a CCR5 defective allele in pediatric HIV-1 infection
39. Protective effect of CCR2-641 and not of CCR5-delta32 and SDF1-3′A in pediatric HIV-1 infection
40. Revised classification system for human immunodeficiency virus infection in children less than 13 years of age
41. Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy
42. Cerebrospinal fluid viral load is related to cortical atrophy and not to intracerebral calcifications in children with symptomatic HIV disease
43. A phase I/II study of the protease inhibitor indinavir in children with HIV infection
44. A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infection
45. Quantitative analysis of viral burden in tissues from adults and children with symptomatic human immunodeficiency virus type 1 infection assessed by polymerase chain reaction
46. Increased human immunodeficiency virus (HIV) type 1 DNA content and quinolinic acid concentration in brain tissues from patients with HIV encephalopathy
47. Dynamics of virus versus host interaction in children with human immunodeficiency virus type 1 infection
48. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4
49. Genetic acceleration of AIDS progression by a promoter variant of CCR5
50. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes
51. HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage
52. Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1
53. Molecular cloning and functional expression of a new human CC-chemokine receptor gene
54. Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: Relationship with viral load
55. Plasma HIV-1 viremia in HIV-1 infected individuals assessed by polymerase chain reaction
56. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection
57. PCR identification of HIV-1 DNA sequences in brain tissue of patients with AIDS encephalopathy
58. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain
59. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage
60. HIV-1-infected long-term slow progressors heterozygous for delta32-CCR5 show significantly lower plasma viral load than wild-type slow progressors
61. Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4
62. Increased level of stromal-cell derived factor-1 mRNA in peripheral blood mononuclear cells from children with AIDS-related lymphoma
63. Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication
64. CCR5/delta(ccr5) heterozygosity: A selective pressure for the syncytium-inducing human immunodeficiency virus type 1 phenotype
65. Early progression of disease in HIV-infected infants with thymus dysfunction
66. CD4+ memory T cells are the predominant population of HIV-1-infected lymphocytes in neonates and children